Is priligy dapoxetine effective for premature ejaculation?

Is priligy dapoxetine effective for premature ejaculation?

Priligy is a brand for Dapoxetine. I have already answered the question about Dapoxetine use and efficacity for PE, so I will just compose a photo summary here and estimate another response.

So in a nutshell, yes Priligy (or even Dapoxetine) is successful. Typically, it makes guys endure from 2.5 to 3x longer. But, it is not the best drug. As you can see on the table Paroxetine is the best drug. However, Dapoxetine is an approved medication for treating PE in certain states while Paroxetine (or some other SSRIs recorded here) are off-label drugs.

Whatever the situation, if you are thinking about medication treatment for premature ejaculation, then you must always talk with your physician first. He is the one which could suggest the ideal medication cure for you.

And for your long response on Dapoxetine vs SSRIs, here you go:

Yes, Dapoxetine is a powerful medication for Premature Ejaculation. Normally, a man who takes 30-60 milligrams of Dapoxetine 1 to 3 hours prior to intercourse will continue between 2.5 to 3x longer. But, it is not the best medication to delay ejaculation. Paroxetine, a sort of SSRI, is the very best medication for PE. However, Dapoxetine has a few benefits over Paroxetine and other SSRIs.

Dapoxetine use for PE is accepted in some states while SSRIs are prescribed .

Dapoxetine use for PE has passed all of the clinical trials to be accepted as a treatment for premature ejaculation in certain states (mostly Europeans ones). But it is not accepted by the FDA at right now, so if you are in the USA, it is not available.SSRIs such as Paroxetine are not accepted in any state for its treatment of PE. But because it is approved for treating additional condition, and a few information demonstrates it efficacity for PE, a physician can prescribe it. That is what we call an off-label usage. Simply speaking, it usually means the pharma which makes the medication can not advertise its drug as a”PE medication” (you can not write on the tag that is successful for PE), however, a physician can prescribe it. Off-labeling is permitted in many countries like USA, UK and Canada.

Dapoxetine within an on-demand usage medication and SSRIs are daily use medication.

You merely take dapoxetine prior sex. SSRIs have to be taken in precisely the exact same hour every day. The advantage of this on-demand drug is you don’t have the medication constantly on your system. It can lessen the possibility of side effects. But as we do not always know ahead of time once we have sex, a few favor the continuous advantage of a daily medication.

Dapoxetine is less successful than SSRIs

As you can see on the table over, SSRIs are more effective at delaying ejaculation. Remedies efficacity for PE is calculated using a device named IELT, or that I ntravaginal Ejaculatory Latency Time (you can find out more here: Dapoxetine for Premature Ejaculation Inspection )If you are thinking about medication treatment for the premature ejaculation problem, the initial step would be to speak to a physician. If you’d like more info on Dapoxetine for treating premature ejaculation, then you are able to assess the link above. But, please be aware that this is not an expert medical opinion. Only a doctor can advise you on the ideal medication treatment on your PE.


  • Pryor JL, Althof SE, Steidle C, Rosen RC, Hellstrom WJ, Shabsigh R et al (2006) Efficacy and tolerability of dapoxetine in therapy of premature ejaculation: an integrated evaluation of 2 double-blind, randomised controlled trials.
  • Of premature ejaculation: outcomes from a randomized, double-blind, placebo-controlled phase 3 trial in 22 nations. Eur Urol 55:957–967 Kaufman JM, Rosen RC, Mudumbi RV, Tesfaye F, Hashmonay R, Rivas D (2009) Remedy advantage of dapoxetine for premature ejaculation: outcomes in a placebo-controlled phase III trial. BJU Int 103:651–658, McMahon C, Kim SW, Park NC, Chang CP, Rivas D, Tesfaye F et al (2010) Treatment of premature ejaculation at the Asia-Pacific area: results from a phase III double-blind,parallel-group analysis of dapoxetine.